Ackrell Capital Cannabis Investment Report shows rapid stock price gains and capital raises in Canadian cannabis sector (Dec 2017)
Summary
The document is a market performance summary with no specific allegations, names of wrongdoing, or actionable leads linking powerful actors to misconduct. It merely reports stock price movements and c Canadian cannabis stocks experienced massive price increases in 2017. Capital raised by publicly traded Canadian cannabis companies is quantified for the 12‑month period The report is produced by Ac
This document is from the House Oversight Committee Releases.
View Source CollectionPersons Referenced (1)
Tags
Related Documents (6)
Cannabis Investment Report – Comparison of U.S. Stock Market Listing Requirements (Dec 2017)
The passage only provides generic data on listing standards for Nasdaq, NYSE, and OTC markets. It contains no references to influential actors, financial flows, misconduct, or investigative leads. Most cannabis‑related public companies trade on the OTC due to looser requirements. Nasdaq and NYSE have higher minimum share prices and stricter governance standards. OTC tiers (OTCQX, OTCQB, OTCPink) v
Canadian Public Cannabis Companies Market Overview (Nov 2017)
The passage provides routine financial statistics on publicly traded cannabis firms in Canada with no indication of wrongdoing, influential actors, or novel controversy. It lacks actionable leads, spe As of Nov 30, 2017, 6 firms on TSX, 20 on TSXV, 41 on CSE. Combined enterprise value of Canadian cannabis firms was $210.6 billion. Stock performance boosted by Trudeau's recreational cannabis announ
Ackrell Capital Cannabis Investment Report Shows Strong Stock Gains Post‑Trump Election
The document is a routine market analysis of publicly traded cannabis companies with no mention of specific individuals, transactions, or wrongdoing. It offers no actionable investigative leads and re U.S. cannabis‑related stocks rose sharply from late 2016 through 2017. The report notes that the election of Donald Trump and appointment of Jeff Sessions did not dampen p Data sourced from S&P Globa
Directory of Private Cannabis Companies Featured in House Oversight Report
The passage lists several private cannabis producers and their products without mentioning any high‑profile individuals, government agencies, financial transactions, or alleged misconduct. It offers n Level Blends – California cannabis concentrate producer. Lunchbox Alchemy – Oregon cannabis edibles and concentrates maker. LivWell Enlightened Health – Colorado/ Oregon dispensary operator and culti
Cannabis Industry Company Listings in 2017 Investment Report
The passage lists several small cannabis businesses and a research firm with no mention of high‑profile officials, financial misconduct, or controversial actions. It provides no actionable leads, date Identifies Auntie Dolores, a cannabis edibles producer in Oakland, CA. Lists BAS Research, a cannabis oil extraction and manufacturing firm in Berkeley, CA. Mentions Baker Technologies, a CRM platfor
Directory of Private Cannabis Companies Listed in House Oversight Document
The passage merely lists cannabis businesses and their websites without any allegations, financial flows, or connections to high‑profile officials. It offers no actionable investigative leads, novelty Names and locations of several private cannabis firms (Beboe, BioTrackTHC, Berkeley Patients Group, Brief description of each company's products or services.
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.